An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors

Clinical trial NCT06942143 · RECRUITING

Trial details

NCT number: NCT06942143
Sponsor: Guangzhou FineImmune Biotechnology Co., LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sarcoma Lung Cancers Melanoma

Start date: 2025-05-22
Primary completion: 2027-04-25
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.